Literature DB >> 33489579

Delayed Hemolytic Transfusion Reaction in a Sickle Cell Disease Patient: A Case Report.

Mohammed Saleh1,2, Vishnu Priya Mallipeddi2, Ahmed Ali3.   

Abstract

Alloimmunization has been reported in patients with sickle cell disease (SCD). Delayed hemolytic transfusion reaction (DHTR) is one of the complications of alloimmunization. DHTR is of particular clinical significance in this patient population as it may pose a diagnostic and management challenge to most healthcare providers. Symptoms of DHTR are often misinterpreted as pain crisis or worsening of baseline anemia. Furthermore, DHTR may take a turn for the worse in patients with SCD, thereby leading to worsening anemia and hyper-hemolytic crisis. In this report, we discuss the case of a 33-year-old African female, with hemoglobin SS (Hb SS) SCD and a history of multiple blood transfusions in her home country of Nigeria, who presented to the emergency department with generalized body pain, which was typical of her prior vaso-occlusive crisis (VOC). The trigger of her crisis was an acute onset of sepsis secondary to Escherichia coli (E. coli)-associated pyelonephritis. Owing to a worsening of her VOC and a significant drop in her steady-state Hb levels, she required a blood transfusion of one unit of packed red blood cells (PRBC), which was later complicated by a delayed hemolytic reaction and worsening anemia.
Copyright © 2020, Saleh et al.

Entities:  

Keywords:  blood transfusion compl; dhtr; sickle cell disease; transfusion reaction

Year:  2020        PMID: 33489579      PMCID: PMC7813152          DOI: 10.7759/cureus.12167

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  8 in total

Review 1.  Transfusion management of sickle cell disease.

Authors:  A S Wayne; S V Kevy; D G Nathan
Journal:  Blood       Date:  1993-03-01       Impact factor: 22.113

2.  Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.

Authors:  David Narbey; Anoosha Habibi; Philippe Chadebech; Armand Mekontso-Dessap; Mehdi Khellaf; Jean-Daniel Lelièvre; Bertrand Godeau; Marc Michel; Frédéric Galactéros; Rachid Djoudi; Pablo Bartolucci; France Pirenne
Journal:  Am J Hematol       Date:  2017-10-31       Impact factor: 10.047

3.  Delayed hemolytic transfusion reaction in children with sickle cell disease.

Authors:  Mariane de Montalembert; Marie-Dominique Dumont; Claire Heilbronner; Valentine Brousse; Oussama Charrara; Béatrice Pellegrino; Christophe Piguet; Valérie Soussan; France Noizat-Pirenne
Journal:  Haematologica       Date:  2011-02-17       Impact factor: 9.941

4.  Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells.

Authors:  K E King; R S Shirey; M W Lankiewicz; J Young-Ramsaran; P M Ness
Journal:  Transfusion       Date:  1997-04       Impact factor: 3.157

5.  The sickle cell hemolytic transfusion reaction syndrome.

Authors:  L D Petz; L Calhoun; I A Shulman; C Johnson; R M Herron
Journal:  Transfusion       Date:  1997-04       Impact factor: 3.157

Review 6.  How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.

Authors:  France Pirenne; Karina Yazdanbakhsh
Journal:  Blood       Date:  2018-05-03       Impact factor: 22.113

7.  Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.

Authors:  Jennifer B Vidler; Kate Gardner; Kenneth Amenyah; Aleksandar Mijovic; Swee L Thein
Journal:  Br J Haematol       Date:  2015-03-05       Impact factor: 6.998

8.  Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

Authors:  Julie-An M Talano; Cheryl A Hillery; Jerome L Gottschall; Diane M Baylerian; J Paul Scott
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

  8 in total
  1 in total

1.  Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease: A Case Series.

Authors:  Abrar J Alwaheed; Safi G Alqatari; Amal S AlSulaiman; Reem S AlSulaiman
Journal:  Am J Case Rep       Date:  2022-01-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.